V. Krishnamurthi et al., Atheroembolic renal disease: Effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis, J UROL, 161(4), 1999, pp. 1093-1096
Purpose: Atheroembolic renal disease is increasingly found in older patient
s with general atherosclerosis, We evaluated the impact of atheroembolic re
nal disease on morbidity and survival after surgical revascularization for
atherosclerotic renal artery stenosis.
Materials and Methods: The study group comprised 44 patients who underwent
surgical revascularization for atherosclerotic renal artery stenosis and co
ncomitant intraoperative renal biopsy. Renal biopsy specimens were reviewed
by a pathologist and evaluated for the presence or absence of atheroemboli
, and the presence and severity of arteriolar nephrosclerosis. Postoperativ
e patient data were reviewed to evaluate survival, and the incidence of ren
al and systemic morbid events. Patients were followed for 1 to 14.5 years (
median 6.2) after surgical revascularization.
Results: Atheroembolic renal disease was identified in the intraoperative b
iopsy specimen in 16 patients (36%, group 1) and was absent in 28 (64%, gro
up 2), termed groups 1 and 2. Atheroembolic renal disease correlated signif
icantly with decreased patient survival. The 5-year survival in groups 1 an
d 2 was 54 and 85%, respectively (p = 0.011). Similarly the incidence of sy
stemic atherosclerotic complications was significantly higher in group 1 th
an group 2 (86 versus 58%, p < 0.05). In addition, renal or renovascular co
mplications developed in more group 1 than group 2 patients (p = 0.07). The
re was no significant association between the presence or severity of arter
iolar nephrosclerosis and postoperative survival or morbid events.
Conclusions: Our results indicate that atheroembolic renal disease is assoc
iated with decreased survival and an increased incidence of atherosclerotic
morbid events after surgical revascularization for atherosclerotic renal a
rtery stenosis. This information may be useful for therapeutic decision mak
ing in patients with atherosclerotic renal artery stenosis.